Latest News
HomeBasant Raj Mishra

Basant Raj Mishra

Executive Chairman Temple Tiger Group of Companies

Basant Raj Mishra, the executive chairman of the Temple Tiger Group of Companies, is a well-known name in the travel trade community. Former chairman of the PATA Nepal Chapter, Secretary of PATA Nepal Chapter, Executive Member of PATA Nepal Chapter, Advisor of PATA Nepal Chapter and Founder Board of Nepal Association Tourism Board (NTB). Mr. Mishra is an energetic and visionary entrepreneur. A widely traveled entrepreneur, he also has been carrying out responsibilities as the Honorary Consul of Republic of Chile to Nepal. Mr. Mishra is a well known person in the field of tourism and conservation, having a lot of experiences in the cultural, adventure and wildlife tourism. Till date Mr. Mishra is very active, enthusiastic in promoting tourism and have served many National and International Board of Trustees. He is running his company very successfully for the last 34 years in Nepal and abroad. He received many national and international awards.

Nepal celebrates a milestone with a remarkable surge in tourism, recording a record-breaking influx of 128,167 tourists in March alone,

In 2023, Nepal celebrated welcoming over a million tourists, showcasing its tourism sector's resilience and growth, driven by strategic initiatives

237,696 foreign tourists have visited Nepal in the last 6 months dated from January to June via Tribhuvan International

The government also plans to attract 1 million international tourists in the coming year.

Nepal has inoculated more than 44 percent of the citizens with a full dose of the vaccine till date.

The cases seem to be plateauing across the country for the past few days now. A total of 3,049 people

Following the global surge in the Omicron variant cases, Nepal has decided to put inbound and outbound ban on both

The COVID cases in the country right now are very low if not the lowest to date. 306 new cases

Nepal was amongst the first country to start the vaccination drive on 27th Jan 2021 with the AstraZeneca vaccine and